Breaking News Instant updates and real-time market news.

TSLA

Tesla

$308.77

11.32 (3.81%)

18:44
01/30/19
01/30
18:44
01/30/19
18:44

Tesla down 4.5% or $13.77 at $295 afterhours following resignation of CFO

  • 30

    Jan

TSLA Tesla
$308.77

11.32 (3.81%)

01/30/19
BARD
01/30/19
NO CHANGE
Target $465
BARD
Outperform
Baird a buyer of Tesla heading into Q4 results
Baird analyst Ben Kallo said he remains a buyer of Tesla heading into Q4 results as he believes the shares are set up for a positive reaction, citing significantly lowered expectations due to the lay-offs and price reductions. Kallo reiterated his Outperform rating and $465 price target on Tesla shares ahead of the company's report, which is due after market close today.
01/29/19
UBSW
01/29/19
NO CHANGE
Target $220
UBSW
Sell
Tesla Q4 results likely to disappoint, says UBS
UBS analyst Colin Langan believes Tesla's Q4 results will disappoint as Model 3 pricing and production volume may fall short of expectations. He believes it will result in a roughly 40% quarter-over-quarter decline in earnings and a decline in margins. Langan reiterated his Sell rating and lowered his price target to $220 from $230 on Tesla shares.
01/28/19
OPCO
01/28/19
NO CHANGE
Target $418
OPCO
Outperform
Product updates from Tesla may help spark investor interest, says Oppenheimer
Oppenheimer analyst Colin Rusch believes Tesla's Model 3 demand, production, and margin are the primary drivers of stock performance in 2019, but numerous additional variables will be increasingly important to investor dialogue starting with this quarter. First, he expects the company to lay out explicit plans on debt repayment and capex for U.S./China capacity. Second, Rusch is expecting an update on the company's product roadmap and timing beyond Model 3. The analyst sees future product updates as an area that may spark near-term investor interest after some disappointment around anticipated CF in Q4. Rusch would remain a buyer into quarterly results. He reiterates an Outperform rating and $418 price target on the shares.
01/25/19
BARD
01/25/19
NO CHANGE
Target $465
BARD
Outperform
Buy Tesla ahead of Q4 report with expectations reset, says Baird
Baird analyst Ben Kallo said he would be a buyer of Tesla into Q4 earnings as he believes that significantly lowered expectations have set the stock up for a positive reaction. He believes management will provide additional data points dispelling demand concerns, highlighting cash generation potential in 1H19, and/or providing guidance on OpEx growth; all of which will be positive catalysts. Kallo reiterated his Outperform rating and $465 price target on Tesla shares.

TODAY'S FREE FLY STORIES

APH

Amphenol

$94.30

-2.64 (-2.72%)

05:12
06/17/19
06/17
05:12
06/17/19
05:12
Downgrade
Amphenol rating change  »

Amphenol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAP

SAP

$127.69

-1.11 (-0.86%)

05:10
06/17/19
06/17
05:10
06/17/19
05:10
Upgrade
SAP rating change  »

SAP upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

E

Eni SpA

$31.24

-0.1 (-0.32%)

05:09
06/17/19
06/17
05:09
06/17/19
05:09
Upgrade
Eni SpA rating change  »

Eni SpA upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQNR

Equinor

$19.44

-0.06 (-0.31%)

05:08
06/17/19
06/17
05:08
06/17/19
05:08
Upgrade
Equinor rating change  »

Equinor upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ROYMY

Royal Mail

$0.00

(0.00%)

05:07
06/17/19
06/17
05:07
06/17/19
05:07
Upgrade
Royal Mail rating change  »

Royal Mail upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOW

Dow Inc.

$51.12

-1.77 (-3.35%)

05:05
06/17/19
06/17
05:05
06/17/19
05:05
Downgrade
Dow Inc. rating change  »

Dow Inc. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRDBY

Nordea Bank

$0.00

(0.00%)

05:04
06/17/19
06/17
05:04
06/17/19
05:04
Downgrade
Nordea Bank rating change  »

Nordea Bank downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$20.53

(0.00%)

05:03
06/17/19
06/17
05:03
06/17/19
05:03
Downgrade
Kinder Morgan rating change  »

Kinder Morgan downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$19.36

-0.22 (-1.12%)

05:00
06/17/19
06/17
05:00
06/17/19
05:00
Upgrade
Symantec rating change  »

Symantec upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OGE

OGE Energy

$43.42

0.17 (0.39%)

04:56
06/17/19
06/17
04:56
06/17/19
04:56
Initiation
OGE Energy initiated  »

OGE Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
06/17/19
06/17
04:55
06/17/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
CLSA India economics & strategy luncheon meeting »

India Strategist…

IR

Ingersoll-Rand

$124.65

0.31 (0.25%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Ingersoll-Rand management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

NTGN

Neon Therapeutics

$4.76

-0.15 (-3.06%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Neon Therapeutics management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

  • 18

    Jun

NVTA

Invitae

$19.20

-0.43 (-2.19%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Invitae participates in a conference call with JPMorgan »

Life Science Tools &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 06

    Aug

DL

China Distance Education

$5.41

(0.00%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
China Distance Education management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

QRTEA

Qurate Retail

$12.83

-0.4 (-3.02%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Qurate Retail management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 20

    Jun

TGODF

The Green Organic Dutchman

$0.00

(0.00%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
The Green Organic Dutchman Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

GNL

Global Net Lease

$19.58

0.13 (0.67%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Global Net Lease management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

ITT

ITT

$62.33

-0.54 (-0.86%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
ITT management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

04:55
06/17/19
06/17
04:55
06/17/19
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Stephens banking analysts to hold an analyst/industry conference call »

Analysts, along with the…

AGTC

Applied Genetic

$3.89

0.04 (1.04%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Applied Genetic management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

AMRS

Amyris

$3.93

-0.16 (-3.91%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Amyris management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

IONS

Ionis Pharmaceuticals

$62.07

-1.79 (-2.80%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Ionis Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.